Intel's Stock Is Soaring. Is It Too Late to Buy?

Intel announced a partnership with Apple to design and manufacture chips in the U.S., a notable validation of Intel's foundry strategy. The stock has already surged more than 260% since the start of 2026, reflecting improved sentiment under CEO Lip-Bu Tan and the U.S. government's nearly 10% stake. However, the article also flags stretched valuation, with forward P/E at 153 and trailing P/E above 900.

Analysis

This is less about a single customer win and more about Intel finally getting a credible external validation point for its manufacturing roadmap. In market terms, that matters because foundry businesses do not re-rate on capability alone; they re-rate when a top-tier, low-tolerance buyer is willing to commit design effort and supply-chain risk. The second-order effect is a potential loop: one marquee win reduces perceived process-risk, which can unlock more design-ins, which in turn improves utilization and lowers per-wafer economics.

The bigger beneficiary may be the domestic supply-chain narrative rather than Apple or Intel alone. If U.S.-based production is now a strategic requirement for high-end silicon, then packaging, advanced substrates, EDA, tools, and specialty materials suppliers tied to onshore capacity get a multi-year demand tailwind. The relative loser is TSMC not from immediate volume loss, but from incremental bargaining power erosion in premium U.S. customer segments if buyers view diversification as a geopolitical hedge rather than a pure cost decision.

The risk is that the market has already moved far ahead of operating proof. A valuation multiple in the triple digits implies flawless execution over several quarters, yet foundry turnarounds typically fail in the middle period: the point where capex rises before yields and customer mix improve. If Intel cannot convert this announcement into a broader customer pipeline within the next 2-4 quarters, the stock is vulnerable to a sharp de-rating even if the headline partnership remains intact.

Consensus may be underestimating how much of the move is policy-driven versus fundamentals-driven. Government backing and U.S.-manufacturing preference can support the equity for years, but that does not automatically translate into durable margin structure. The contrarian setup is that Intel can remain strategically important while still being a poor marginal return on capital at current expectations; that gap is where the trade risk sits.

Key Decisions for Investors

• Long INTC only on pullbacks, not strength; use a 3-6 month entry window and size for a binary execution story. Prefer scaling in below recent breakout levels because the upside depends on follow-through customer announcements, not the current headline.
• Pair trade: long INTC / short TSM over the next 6-12 months as a relative-value hedge on U.S. onshoring and customer diversification. The pair works only if Intel wins additional design-ins; cover if Intel fails to announce a second anchor customer within two quarters.
• Buy call spreads on INTC expiring in 6-9 months to express upside with defined risk. Structure around a post-announcement digestion period, since the stock is vulnerable to mean reversion if investors start pricing in execution delays.
• Add AAPL only as a tactical beneficiary of supply-chain optionality, not as a thesis driver. Any position should be small and short-dated, since the strategic benefit to Apple is real but unlikely to materially change near-term earnings.
• Monitor U.S.-based semiconductor equipment and packaging names for secondary upside over 12-24 months; if Intel’s foundry traction broadens, the cleaner trade may be the picks-and-shovels rather than the high-beta headline name.